Katherine B. Peters, MD, PhD
Neuro-oncologist
My Locations
About Me
I am a neurologist and cancer doctor who treats brain tumors and researches ways to improve quality of life for brain tumor patients. As a college student, I thought I was going to be a scientist, but fell in love with studying the brain and its inner workings. I enjoy being at Duke, because I work with some of the top clinicians and researchers in the field, and a generous and warm-hearted staff that helps patients and their loved ones through treatment. It is hard to pick one thing I enjoy about my job. I enjoy seeing patients and their loved ones, being at the cutting edge of research and teaching the next generation of doctors. I think it is the chance to do so many different things that makes my job special. Outside of work, I enjoy shopping at farmer’s markets, cooking and exercising. I also collect Swatch watches - I have over 400!
- Professor of Neurosurgery, Neurosurgery, Neuro-Oncology 2023
- Vice Chair for Education in the Department of Neurology, Neurology 2022
- Professor in Neurology, Neurology 2023
Call for an Appointment
Areas of Expertise
Ratings and Reviews
The ratings and reviews are based on patient responses to the overall provider rating question from the survey. The question reads: “Using any number from 0 to 10, where 0 is the worst provider possible and 10 is the best provider possible, what number would you use to rate this provider?” Responses are converted to a 5-point rating system and applied consistently to all providers. Learn more about our survey process. Patients who see some types of providers receive a different version of the patient satisfaction survey. Those results are not available on DukeHealth.org.
Training and Education
In the News
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Clinical Focus and Research
My area of research includes studying and developing treatments for brain tumors and how to improve a patient's quality of life during and after treatment. Treatment of brain cancer can lead to difficulties with memory, difficulties with thinking, seizures, fatigue, nausea and vomiting. I help design clinical trials that are aimed at preventing and treating memory and thinking problems, seizures, fatigue, nausea, and vomiting.
-
ViSPad Supportive Care Study for Brain Tumor PatientsIRB# PRO00110745
-
Ketogenic Diet with Standard Treatment for Newly Diagnosed GBM (Glioblastoma)IRB# PRO00108622 , NCT# NCT05708352
-
Curis CA-4948-101 (Primary Central Nervous System Lymphoma)IRB# PRO00115450 , NCT# NCT03328078
-
NMS-03305293 and Temozolomide in Adult Patients with Recurrent Glioblastoma (PARPA-293-002)IRB# PRO00115326 , NCT# NCT04910022
-
Repeatability of Magnetic Resonance Imaging in Patients with IDH1 Mutant Glioma on IvosidenibIRB# PRO00116521 , NCT# NCT06648473
- Horbinski, Craig, David A. Solomon, Rimas V. Lukas, Roger J. Packer, Priscilla Brastianos, Patrick Y. Wen, Matija Snuderl, et al. “Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review.” JAMA Oncol 11, no. 3 (March 1, 2025): 317–28. https://doi.org/10.1001/jamaoncol.2024.5506.
- Walbert, Tobias, Edward K. Avila, Florien W. Boele, Caroline Hertler, Christine Lu-Emerson, Pim B. van der Meer, Katherine B. Peters, Alasdair G. Rooney, Jessica W. Templer, and Johan A. F. Koekkoek. “Symptom management in isocitrate dehydrogenase mutant glioma.” Neurooncol Pract 12, no. Suppl 1 (February 2025): i38–48. https://doi.org/10.1093/nop/npae088.
- Patel, Mallika P., Mary Lou Affronti, Evan D. Buckley, James E. Herndon Ii, Emma M. Mackowsky, Margaret O. Johnson, and Katherine B. Peters. “Financial toxicity of oral chemotherapy in patients with primary brain tumors.” Neuro-Oncology Practice 12, no. 1 (February 2025): 153–59. https://doi.org/10.1093/nop/npae073.
- Peters, K. B. “Health-related quality of life in glioma patients.” In The Duke Glioma Handbook: Pathology, Diagnosis, and Management, 190–204, 2016. https://doi.org/10.1017/CBO9781107588721.010.
- Peters, K. B., and D. N. Irani. “Connective Tissue, Endocrine, Toxic, and Psychiatric Disorders.” In Cerebrospinal Fluid in Clinical Practice, 135–43, 2008. https://doi.org/10.1016/B978-141602908-3.50020-0.
- Kim, J. Y., J. C. Dalton, N. Cort, J. E. Herndon, M. L. Affronti, K. B. Peters, C. A. Jones, and M. O. Johnson. “Comparing Knowledge and Perceptions of Palliative Care Among Neuro-Oncology Patients, Caregivers, and Providers to a Representative U.S. Sample.” In American Journal of Hospice and Palliative Medicine, 2024. https://doi.org/10.1177/10499091241280610.
- Mrugala, M. M., Q. T. Ostrom, S. M. Pressley, J. W. Taylor, A. A. Thomas, J. S. Wefel, S. L. Coven, et al. “The state of neuro-oncology during the COVID-19 pandemic: A worldwide assessment.” In Neuro-Oncology Advances, Vol. 3, 2021. https://doi.org/10.1093/noajnl/vdab035.
- Huang, Raymond Y., Robert J. Young, Benjamin M. Ellingson, Harini Veeraraghavan, Wei Wang, Florent Tixier, Hyemin Um, et al. “Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatment.” In Neuro Oncol, 22:1822–30, 2020. https://doi.org/10.1093/neuonc/noaa105.
Insurance Accepted
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
-
Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Value Plan (HMO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Aetna/CVS Health
-
Ambetter
- Ambetter of North Carolina
-
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
-
*Duke HomeCare and Hospice does not participate in the plan.
-
Cigna
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
-
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
-
Duke Group Plans
- Duke Basic
- Duke Select
-
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
- Gateway Health Alliance
- Healthgram
-
Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- MedCost
-
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
-
NC Medicaid
- AmeriHealth Caritas North Carolina
- Carolina Complete Health
- Healthy Blue
- NC Medicaid Direct
- WellCare of North Carolina
-
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
-
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)**
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
-
*Duke HomeCare and Hospice and mental health providers do not participate with the plan.
-
**Duke Health does not participate in UHC plans on the Health Insurance Marketplace.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.
External Relationships
- Ono pharma USA, Inc.
- Pathos
- Rigel Pharmaceuticals, Inc
- Sapience
- Servier
- telix pharmaceuticals